- Home
- PAVS vs PROK Comparison
PAVS vs PROK Comparison
Compare PAVS & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- PROK
- Stock Information
- Founded
- PAVS 2004
- PROK 2015
- Country
- PAVS United States
- PROK United States
- Employees
- PAVS N/A
- PROK N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAVS Health Care
- PROK Health Care
- Exchange
- PAVS Nasdaq
- PROK Nasdaq
- Market Cap
- PAVS 89.6M
- PROK 94.9M
- IPO Year
- PAVS 2019
- PROK N/A
- Fundamental
- Price
- PAVS $1.03
- PROK $0.72
- Analyst Decision
- PAVS
- PROK Buy
- Analyst Count
- PAVS 0
- PROK 4
- Target Price
- PAVS N/A
- PROK $5.00
- AVG Volume (30 Days)
- PAVS 26.8K
- PROK 1.1M
- Earning Date
- PAVS 01-01-0001
- PROK 05-16-2025
- Dividend Yield
- PAVS N/A
- PROK N/A
- EPS Growth
- PAVS N/A
- PROK N/A
- EPS
- PAVS N/A
- PROK N/A
- Revenue
- PAVS $6,613,273.00
- PROK $76,000.00
- Revenue This Year
- PAVS N/A
- PROK N/A
- Revenue Next Year
- PAVS N/A
- PROK N/A
- P/E Ratio
- PAVS N/A
- PROK N/A
- Revenue Growth
- PAVS 2.50
- PROK N/A
- 52 Week Low
- PAVS $0.32
- PROK $0.46
- 52 Week High
- PAVS $1.50
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- PAVS 17.87
- PROK 42.92
- Support Level
- PAVS $1.22
- PROK $0.94
- Resistance Level
- PAVS $1.40
- PROK $0.77
- Average True Range (ATR)
- PAVS 0.06
- PROK 0.12
- MACD
- PAVS -0.03
- PROK -0.01
- Stochastic Oscillator
- PAVS 6.40
- PROK 21.71
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.